:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/WBQR37QIBBCB5IUU5XHSWHYTAI.jpg?resize=560%2C373&ssl=1)
The second dose of Pvizer’s COVID-19 vaccine may be withdrawn to cover all priority groups, the first of which is highly protective, dijeron of Canadian investigators on a map published on the New England Journal of Medicine.
The vaccine contains an efficacy of 92.6% after the first dose, dijeron Danuta Skowronski and Gaston De Serres, based on an analysis of the documents presented by the Pharmaceuticals to the Food and Drug Administration (FDA).
Estos hallazgos fueron similar to the first dose efficacy of 92.1% reported for the vacerna mRNA-1273 de Moderna, according to the map here the Wednesday schools.
In his reply, Pfizer says alternative vaccination regimen regimens have not been evaluated and that the decision resides in health authorities.
Some countries, which are affiliated with the electorate, are analyzing dosage patterns or volumes that differ in how the vacancies are tested in clinical trials.
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/KEFOBEX32EF2MHE7XDL6S5PX6Y.jpg?resize=560%2C373&ssl=1)
There are differences in the merits of strategic strategies, and some argue that the urgency of the pandemic requires flexibility, while others are opposed to abandoning the bases based on dates within the scope of the convention.
Skowronski and De Serres advise that you may have an overdose on the duration of protection with a single dose, but it would be better if the administration of the second dose had one of the first proportions of “additional benefits in the short term”.
Skowronski works at the British Columbia Center for the Control of Sickness, while De Serres is from the National Health Institute of Quebec.
In Great Britain, the authorities say that the dates followed by his decision to move to a 12-week dosing program for the Pfizer COVID vehicle. Like Pfizer as its BioNTech company, it advertises that it does not test to demonstrate.
The Pfizer vaccine is authorized to take 21 different days.
The EDA FDA. UU. and the European Medicines Agency has been tested at intervals in the trials.
The petition of Canadian investigators alleges that Pfizer and Modern announced that the South African variant of coronavirus can reduce the protection of anticurs, whichever is entered into if the injection will be effective against the mutation.
(Reuters info)
SEGUIR LEYENDO: